NASDAQ · Healthcare · Biotechnology
NeuroSense Therapeutics Ltd.
NRSN
NeuroSense Therapeutics Ltd. CEO Alon Ben-Noon · Market cap $13.3M.
$0.38
+0.03 · +7.39%
52w hi $1.9852w lo $0.25
Off 52w high 72.0%
72
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 16 | Or Eisenberg | Chief Financial Officer | Buy | 250,000 | $0.80 | +$200K | 72 |
| Jun 16 | Alon Ben-Noon | Chief Executive Officer | Buy | 250,000 | $0.80 | +$200K | 72 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug